InsiderTrades

Form 4 for XYL Xylem Inc.

Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-14 · accession 0001562180-24-001390 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-16 2024-02-14 XYL Aulick Rodney SVP, Pres, WSS M - OptEx $43.50 +23.9K 104.4K +30% +$1.04M
D 2024-02-16 2024-02-14 XYL Aulick Rodney SVP, Pres, WSS S - Sale+OE $122.55 -23.9K 80.5K -23% -$2.93M
D 2024-02-16 2024-02-14 XYL Aulick Rodney SVP, Pres, WSS M - OptEx $0.00 -23.9K 23.9K -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-14 M A 23,870 $43.50 104,365 D — —
2 Common Common Stock 2024-02-14 S D 23,870 $122.55 80,495 D — — (F1) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 23,870 Shares were executed at a range of prices from $122.45 to $123.4499. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
3 Derivative Non-Qualified Stock Option (Right to Buy) 2024-02-14 M D 23,870 $0.00 23,870 D $43.50 · — to 2028-04-02 23,870 Common Stock (F2) The April 2, 2018 option grant vested one fourth on January 1, 2019, January 1, 2020, January 1, 2021, and January 1, 2022.